Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Net Cash Flow (2023 - 2025)

Guardian Pharmacy Services' Net Cash Flow history spans 3 years, with the latest figure at $29.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 189.47% year-over-year to $29.1 million; the TTM value through Dec 2025 reached $61.0 million, up 1459.85%, while the annual FY2025 figure was $61.0 million, 1459.85% up from the prior year.
  • Net Cash Flow for Q4 2025 was $29.1 million at Guardian Pharmacy Services, up from $17.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $35.7 million in Q3 2024 and bottomed at -$32.6 million in Q4 2024.
  • The 3-year median for Net Cash Flow is $4.8 million (2025), against an average of $7.2 million.
  • The largest annual shift saw Net Cash Flow plummeted 24955.73% in 2024 before it surged 1715.74% in 2025.
  • A 3-year view of Net Cash Flow shows it stood at $131000.0 in 2023, then tumbled by 24955.73% to -$32.6 million in 2024, then surged by 189.47% to $29.1 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Net Cash Flow are $29.1 million (Q4 2025), $17.7 million (Q3 2025), and $4.8 million (Q2 2025).